Cargando…
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
Interactions of isavuconazole and colistin were evaluated against 57 common Candida strains belonging to the species Candida albicans (n = 10), Candida glabrata (n = 10), Candida kefyr (n = 8), Candida krusei (n = 10), Candida parapsilosis (n = 9), and Candida tropicalis (n = 10) by a broth microdil...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100415/ https://www.ncbi.nlm.nih.gov/pubmed/35573795 http://dx.doi.org/10.3389/fcimb.2022.892893 |
_version_ | 1784706846567694336 |
---|---|
author | Schwarz, Patrick Nikolskiy, Ilya Bidaud, Anne-Laure Sommer, Frank Bange, Gert Dannaoui, Eric |
author_facet | Schwarz, Patrick Nikolskiy, Ilya Bidaud, Anne-Laure Sommer, Frank Bange, Gert Dannaoui, Eric |
author_sort | Schwarz, Patrick |
collection | PubMed |
description | Interactions of isavuconazole and colistin were evaluated against 57 common Candida strains belonging to the species Candida albicans (n = 10), Candida glabrata (n = 10), Candida kefyr (n = 8), Candida krusei (n = 10), Candida parapsilosis (n = 9), and Candida tropicalis (n = 10) by a broth microdilution checkerboard technique based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methodology for antifungal susceptibility testing. Results were analyzed with the fractional inhibitory concentration index and by the response surface analysis. Interpretation by the fractional inhibitory concentration index showed synergy for 50%, 80%, 90%, and 90% of the C. kefyr, C. krusei, C. glabrata, and C. tropicalis strains, respectively. Combination of isavuconazole with colistin against C. albicans and C. parapsilosis exhibited only indifference for 100% and 90% of the strains, respectively. The results were confirmed by response surface analysis for all species except for C. glabrata, for which an indifferent interaction was found for the majority of strains. Antagonistic interaction was never seen regardless of the interpretation model was used. |
format | Online Article Text |
id | pubmed-9100415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91004152022-05-14 In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species Schwarz, Patrick Nikolskiy, Ilya Bidaud, Anne-Laure Sommer, Frank Bange, Gert Dannaoui, Eric Front Cell Infect Microbiol Cellular and Infection Microbiology Interactions of isavuconazole and colistin were evaluated against 57 common Candida strains belonging to the species Candida albicans (n = 10), Candida glabrata (n = 10), Candida kefyr (n = 8), Candida krusei (n = 10), Candida parapsilosis (n = 9), and Candida tropicalis (n = 10) by a broth microdilution checkerboard technique based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methodology for antifungal susceptibility testing. Results were analyzed with the fractional inhibitory concentration index and by the response surface analysis. Interpretation by the fractional inhibitory concentration index showed synergy for 50%, 80%, 90%, and 90% of the C. kefyr, C. krusei, C. glabrata, and C. tropicalis strains, respectively. Combination of isavuconazole with colistin against C. albicans and C. parapsilosis exhibited only indifference for 100% and 90% of the strains, respectively. The results were confirmed by response surface analysis for all species except for C. glabrata, for which an indifferent interaction was found for the majority of strains. Antagonistic interaction was never seen regardless of the interpretation model was used. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9100415/ /pubmed/35573795 http://dx.doi.org/10.3389/fcimb.2022.892893 Text en Copyright © 2022 Schwarz, Nikolskiy, Bidaud, Sommer, Bange and Dannaoui https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Schwarz, Patrick Nikolskiy, Ilya Bidaud, Anne-Laure Sommer, Frank Bange, Gert Dannaoui, Eric In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species |
title |
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species |
title_full |
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species |
title_fullStr |
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species |
title_full_unstemmed |
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species |
title_short |
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species |
title_sort | in vitro synergy of isavuconazole combined with colistin against common candida species |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100415/ https://www.ncbi.nlm.nih.gov/pubmed/35573795 http://dx.doi.org/10.3389/fcimb.2022.892893 |
work_keys_str_mv | AT schwarzpatrick invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies AT nikolskiyilya invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies AT bidaudannelaure invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies AT sommerfrank invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies AT bangegert invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies AT dannaouieric invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies |